<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16(6)</volume><submitter>Cui Z</submitter><funding>Jiaxing Science and Technology Plan Project</funding><funding>Key Construction Disciplines of Provincial and Municipal Co-construction of Zhejiang</funding><funding>Jiaxing Key Laboratory of Precision Treatment for Lung Cancer, Scientific Technology Plan Program for Healthcare in Zhejiang Province</funding><funding>The Key Discipline of Jiaxing General Practice Medicine Construction Project</funding><funding>Jiaxing Fight Novel Coronavirus Pneumonia Emergency Technology Attack Special Research in 2020</funding><journal>Journal of thoracic disease</journal><pagination>3606-3622</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11228754</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Efficacy and safety of casirivimab and imdevimab for preventing and treating COVID-19: a systematic review and meta-analysis</pubmed_title><pmcid>PMC11228754</pmcid><funding_grant_id>No. 2021KY1100</funding_grant_id><funding_grant_id>No. 2019-fc-03</funding_grant_id><funding_grant_id>No. 2023-SSGJ-002</funding_grant_id><funding_grant_id>No. 2020GZ30001</funding_grant_id><funding_grant_id>No. 2022AD30055</funding_grant_id><pubmed_authors>Zou H</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Cui Z</pubmed_authors><pubmed_authors>Chen W</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Li L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Efficacy and safety of casirivimab and imdevimab for preventing and treating COVID-19: a systematic review and meta-analysis</name><description/><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jun</publication><modification>2025-04-26T05:40:30.798Z</modification><creation>2025-04-06T11:36:05.947Z</creation></dates><accession>S-EPMC11228754</accession><cross_references/></HashMap>